AIM ImmunoTech Inc. (AIM) News & Info.

#ThinkSabio Latest News

AIM ImmunoTech Announces that Analysis of AMP-518 Complete Clinical Patient Data Underscores Ampligen’s Potential to Improve the Post-COVID Condition of Fatigue